Skip to content

Management of Obesity with Ayurvedic medicines and Lifestyle modifications

A single blind randomized clinical study comparing Mu?kak ?di ga?a ghanava?i and Navakaguggulu along with lifestyle modification in Sthaulya (Obesity) - Obesity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034849
Enrollment
100
Registered
2021-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

Intervention1: NIL: NIL Intervention2: " Navaka Guggulu, Muskakadi gana ghanavati": 1. Navak Guggulu- 4 tab (500mg) TDS for 8 weeks 2. Muskakadi gana ghanavati-4 tab (500mg) TDS for 8 weeks Control In

Sponsors

J S Ayurveda College and P D Patel Ayurveda hospital NADIAD
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient fulfilling the above criteria of diagnosis for Sthaulya (Obesity)

Exclusion criteria

Exclusion criteria: 1. Patient having endocrinal diseases e.g Hypothyrosim, Cushing’s syndrome, Acromegaly, etc 2. Drug-induced obesity e.g patients taking antidepressants, corticosteroids, hypnotics, etc. 3. Patient having gynecological diseases e.g. PCOD, PCOS, etc 4. Patient having a systemic illness like Tuberculosis, Carcinoma, Hypertension, Diabetes mellitus, Coronary artery diseases, major Renal or Liver disorder, etc 5. Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Effect of Muskakadi ghana ghanavati and Navak guggulu and Lifestyle modification in management of ObesityTimepoint: at the time of enrollment(Before treatment), at 4th weeks (during treatment) and at 8th weeks (after treatment)

Secondary

MeasureTime frame
Weight, Body fat percentage, BMI, Waist circumference Waist Hip ratio, Sign and symptoms of sthaulya, (OWLQOL) 17-Item Questionnaire,8. Weight-Related Symptom Measure (WRSM)Timepoint: at 4th weeks (during treatment) and at 8th weeks (after treatment)

Countries

India

Contacts

Public ContactShivaranjani Kantharia

J.S. Ayurveda Mahavidyalaya, Nadiad

manishayu97@yahoo.com9979589865

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026